PropThink: Nuvo and Galderma Win FDA Approval For Pliaglis Topical Peel

[ACN Newswire] – By David MoskowitzCanadian-based Nuvo Research (TSE:NRI) announced Monday morning that the FDA has approved its Pliaglis product, a unique local anesthetic designed to minimize pain during aesthetic dermatological … more

View todays social media effects on COV

View the latest stocks trending across Twitter. Click to view dashboard